AC
CANO

Addison Capital’s Cano Health, Inc. CANO Stock Holding History

Addison Capital’s Portfolio CANO Stock Details CANO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,722
Closed -$69K – 115
2023
Q3 		$69K Sell
2,722
-197
-7% -$16.2K 0.05% 100
2023
Q2 		$405K Sell
2,919
-30
-1% -$3.85K 0.29% 69
2023
Q1 		$268K Sell
2,949
-1,797
-38% -$244K 0.2% 90
2022
Q4 		$650K Sell
4,746
-87
-2% -$29.5K 0.41% 58
2022
Q3 		$4.19M Hold
4,833
– – 2.59% 8
2022
Q2 		$2.12M Sell
4,833
-184
-4% -$96K 1.24% 29
2022
Q1 		$3.19M Buy
5,017
+385
+8% +$243K 1.52% 18
2021
Q4 		$4.13M Buy
4,632
+387
+9% +$407K 1.85% 19
2021
Q3 		$5.38M Buy
+4,245
New +$5.14M 2.49% 10

Other funds holding CANO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CCM
Connective Capital Management Palo Alto, California $142M AUM 51.29% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Addison Capital's CANO Position: Q4 2023 in Review

Addison Capital sold out of Cano Health, Inc. (CANO) in Q4 2023, closing a stake of 2,722 shares — an estimated $69K sold.

Addison Capital first reported a position in CANO in Q3 2021 and held it in 9 quarters. The position peaked at $5.38M in Q3 2021. 50 funds tracked by Wall St. Rank hold CANO as of Q4 2023.

  • Addison Capital reported no remaining Cano Health, Inc. position as of Q4 2023 after selling out during the quarter.
  • Addison Capital sold 2,722 Cano Health, Inc. shares in Q4 2023, an estimated $69K.
  • Addison Capital first reported a position in Cano Health, Inc. in Q3 2021 and held it in 9 quarters.
  • Addison Capital's Cano Health, Inc. position peaked at $5.38M in Q3 2021.
  • 50 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q4 2023.

Based on Addison Capital's 13F filing for Q4 2023, filed 8 Feb 2024.